25 years as an experienced pharma R&D leader and executive; CSO Agenus, former Roche Palo Alto president; CEO of Kinemed; President & CSO of Incyte; EVP of Research at DuPont-Merck.
25 years of experience in mitochondrial disease pathophysiological mechanism, 10 years of experience in mitochondrial disease therapeutics.
Over 10 years of experience studying signal transduction of aging and metabolic disorders.
Scientist at Janssen Pharmaceutical, subsidiary of Johnson & Johnson. Over 15 years of R&D experience in preclinical drug discovery; former Roche Palo Alto research scientist in neuroscience and inflammation therapy areas.
Over 15 years of R&D experience in drug discovery, CSO Seahorse Bio, former senior management positions at Guava Technologies and Rigel Pharmaceuticals.
Ph.D. Pharmacology and Toxicology
© 2017 Ixchel Pharma